Profhilo® is based on IBSA’s patented technology. It uses stable, hybrid cooperative complexes of Hyaluronic Acid (HA) at high and low molecular weights. This technology has allowed IBSA to present a unique concentration of Hyaluronic Acid to the market. The hybrid cooperative complexes generate a dual action, owing to a slow, long-lasting release of high and low molecular weight Hyaluronic Acid.
Thanks to the unique characteristics of Profhilo®, remodelling skin laxity is possible in just two sessions by injecting into in the superficial subcutaneous layer of the skin. There’s a one month interval between each treatment. Profhilo® may be injected using all aesthetic techniques, according to the suggested injection layer:
• Hydrating and stimulating action, related to low molecular weight (L-HA) HYDRO2.
• Dermal scaffold action (support), related to high molecular weight (H-HA) LIFT3.